Cochrane Abstracts
Newer generation antidepressants for depressive disorders in children and adolescents
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Newer Generation Antidepressants for Depressive Disorders in Children and Adolescents." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432169/all/Newer_generation_antidepressants_for_depressive_disorders_in_children_and_adolescents.
Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432169/all/Newer_generation_antidepressants_for_depressive_disorders_in_children_and_adolescents. Accessed January 23, 2025.
Newer generation antidepressants for depressive disorders in children and adolescents. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432169/all/Newer_generation_antidepressants_for_depressive_disorders_in_children_and_adolescents
Newer Generation Antidepressants for Depressive Disorders in Children and Adolescents [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432169/all/Newer_generation_antidepressants_for_depressive_disorders_in_children_and_adolescents.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Newer generation antidepressants for depressive disorders in children and adolescents
ID - 432169
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432169/all/Newer_generation_antidepressants_for_depressive_disorders_in_children_and_adolescents
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
